ABIVAX Upcoming Events

March 12, 2018
PDF Version
  • 2017 Financial Results to be announced on March 16, 2018

PARIS, Mar. 12, 2018, 8:30 pm. CET – ABIVAX (Euronext Paris: FR0012333284 – ABVX), a biotechnology company harnessing the immune system to develop a functional cure for HIV and treatments for inflammatory/autoimmune diseases and cancer, today announces that its senior management team will participate in upcoming events for investors and business development professionals.

  • March 12-14, 2018: BIO-Europe Spring in Amsterdam
    • Prof. Hartmut Ehrlich, M.D., CEO ABIVAX, will give a corporate update presentation on ABIVAX on Tuesday, March 13 at 11:00 in room E105
  • March 16, 2018: Full Year 2017 Financial Results

 

  • March 19-20, 2018: BIO Asia International Conference in Tokyo

 

  • April 8-10, 2018: H.C. Wainwright Global Life Sciences Conference in Monaco